DE102005027905A8 - A preparation for the prophylaxis and therapy of stress states, of functional and organic disorders of the nervous system and of the metabolism - Google Patents

A preparation for the prophylaxis and therapy of stress states, of functional and organic disorders of the nervous system and of the metabolism Download PDF

Info

Publication number
DE102005027905A8
DE102005027905A8 DE102005027905A DE102005027905A DE102005027905A8 DE 102005027905 A8 DE102005027905 A8 DE 102005027905A8 DE 102005027905 A DE102005027905 A DE 102005027905A DE 102005027905 A DE102005027905 A DE 102005027905A DE 102005027905 A8 DE102005027905 A8 DE 102005027905A8
Authority
DE
Germany
Prior art keywords
prophylaxis
metabolism
therapy
functional
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102005027905A
Other languages
German (de)
Other versions
DE102005027905A1 (en
Inventor
Egon Tech
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE202004009180U external-priority patent/DE202004009180U1/en
Priority claimed from DE202004009689U external-priority patent/DE202004009689U1/en
Application filed by Individual filed Critical Individual
Priority to DE102005027905A priority Critical patent/DE102005027905A1/en
Publication of DE102005027905A1 publication Critical patent/DE102005027905A1/en
Publication of DE102005027905A8 publication Critical patent/DE102005027905A8/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations

Abstract

Präparat zur Prophylaxe und Therapie von Stresszuständen, von funktionellen und organsichen Störungen des Nervensystems und des Stoffwechsels, für die Anwendung bei Sonnenallergikern, gegen Sonnenbrand, als Regenerativ geschädigter Zellen/Zellsysteme und für das Wohlbefinden bei Mensch und Tier sowie Verfahren zur Isolierung von Zellbestandteilen aus Aloe barbadensis miller, zur Herstellung von energetisierten/magnetisierten Mikro- und Nanopartikeln und Verwendung von Zellbestandteilen. DOLLAR A Bisherige Mittel zum Einsatz bei den oben genannten Indikationen sind kostenintensiv in der Herstellung oder haben nur ungenügende Wirkeigenschaften, Präparate, enthaltend Glycin, insbesondere in einer Gel-Formulierung, haben sich als einfach herzustellende Mittel und als überraschend vorteilhaft bei den verschiedensten Applikationen herausgestellt. Die Präparate eignen sich aufgrund der hervorragenden Eigenschaften von Glycin für die einfach umzusetzende äußere und/oder innere Anwendung und bieten damit eine effektive Prophylaxe und Behandlungsmöglichkeiten der unterschiedlichen betroffenen Körperbereiche bzw. der Verbesserung des gefühlten Zustands.A preparation for the prophylaxis and therapy of stress states, of functional and organic disorders of the nervous system and metabolism, for use in sun allergic patients, against sunburn, as regeneratively damaged cells / cell systems and for the well-being of humans and animals, as well as methods for the isolation of cell components from aloe barbadensis miller, for the production of energized / magnetized micro- and nanoparticles and the use of cell components. DOLLAR A Previous means for use in the above indications are costly to manufacture or have insufficient activity properties, preparations containing glycine, especially in a gel formulation have been found to be easy to produce means and as surprisingly advantageous in a variety of applications. Due to the outstanding properties of glycine, the preparations are suitable for easy external and / or internal application and thus offer effective prophylaxis and treatment options for the different affected areas of the body or for improving the perceived state.

DE102005027905A 2004-06-11 2005-06-10 Combating stress states or nervous system or metabolic disorders, using glycine as neurotransmission modulator showing antistress, stress protective, nootropic and toxin binding actions Withdrawn DE102005027905A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE102005027905A DE102005027905A1 (en) 2004-06-11 2005-06-10 Combating stress states or nervous system or metabolic disorders, using glycine as neurotransmission modulator showing antistress, stress protective, nootropic and toxin binding actions

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE202004009180.1 2004-06-11
DE202004009180U DE202004009180U1 (en) 2004-06-11 2004-06-11 Formulation comprising glycine-containing gel, useful, by external or internal application, for treatment or prevention of e.g. allergy, sunburn and stress
DE202004009689U DE202004009689U1 (en) 2004-06-18 2004-06-18 Combating stress states or nervous system or metabolic disorders, using glycine as neurotransmission modulator showing antistress, stress protective, nootropic and toxin binding actions
DE202004009689.7 2004-06-18
DE102005027905A DE102005027905A1 (en) 2004-06-11 2005-06-10 Combating stress states or nervous system or metabolic disorders, using glycine as neurotransmission modulator showing antistress, stress protective, nootropic and toxin binding actions

Publications (2)

Publication Number Publication Date
DE102005027905A1 DE102005027905A1 (en) 2005-12-29
DE102005027905A8 true DE102005027905A8 (en) 2006-07-27

Family

ID=35455205

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102005027905A Withdrawn DE102005027905A1 (en) 2004-06-11 2005-06-10 Combating stress states or nervous system or metabolic disorders, using glycine as neurotransmission modulator showing antistress, stress protective, nootropic and toxin binding actions

Country Status (1)

Country Link
DE (1) DE102005027905A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006051941A1 (en) 2006-01-24 2007-07-26 Egon Tech Multifunctional active agent mixture, useful as auxiliary material in virus vaccine or vaccine to treat cancer, comprises fraction of specific peptide in polypetide chain and fraction with essential and non-essential amino acids
AT513775B1 (en) * 2012-12-20 2019-06-15 Ybes Liegenschaften Gmbh Process for the preparation of a cosmetic preparation and cosmetic preparation

Also Published As

Publication number Publication date
DE102005027905A1 (en) 2005-12-29

Similar Documents

Publication Publication Date Title
CN103054989B (en) Compound essential oil for preventing and treating psoriasis as well as preparation method thereof
CN114099409A (en) Soothing and repairing composition and application thereof
EP1952799A3 (en) Cosmetic preparation with hyaluronic acid and saponins to treat signs of skin ageing
CN109350564A (en) A kind of resurrection is careless to repair stoste and preparation method thereof
CN106420395A (en) Anti-allergy regenerative mask fluid
BRPI0607967A2 (en) hair and / or scalp care compositions, method for treating and / or preventing inflammatory skin disorders, use of visnadine and use of a composition
CN1301745C (en) Chinese medicinal liquid for treating alopecia and its production method
DE102005027905A8 (en) A preparation for the prophylaxis and therapy of stress states, of functional and organic disorders of the nervous system and of the metabolism
EP2018849A3 (en) Cosmetic method for manipulating the skin
WO2005120487A3 (en) Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders
CN115054566B (en) Scalp aging resisting composition and preparation method thereof
CN116172914A (en) Fermentation composition and preparation method and application thereof
EP3036003A1 (en) Diffusion pigments in phototherapy
Matthews-Brzozowska et al. Mesotherapy–a method of facial skin rejuvenation from an interdisciplinary perspective on improving facial aesthetics
DE10043982A1 (en) Process for improving the hair growth of human hair
CN101623487A (en) Chinese medicinal composition for treating alopecia areata
CN110478310A (en) A kind of composition for the treatment of and Reduce allergy
IT201800011056A1 (en) COMPOSITION FOR THE PREVENTION AND TREATMENT OF SKIN DISEASES
DE202018102553U1 (en) Composition for promoting hair growth
Scarci et al. In Vitro Evaluations for a New Topical Anti-Aging Formulation
DE102017010100A1 (en) Device for improving the skin appearance and metabolism
DE202009013734U1 (en) Mineral powder mixture
KR20160094058A (en) Compositions for hair growth promoting and anti-dandruff
EP1342468A1 (en) New cosmetic raw materials from plants of the family Zosteraceae for special cosmetic effects and uses
DE102012023927A1 (en) Ointment useful for treating psoriasis without side effects, comprises natural materials, extracts of salt pork, white beeswax and lavender oil, and does not contain preservatives

Legal Events

Date Code Title Description
8196 Reprint of faulty title page (publication) german patentblatt: part 1a6
8139 Disposal/non-payment of the annual fee